In his NYT newsletter piece making the case for creative public action on vaccine and drug development David Wallace Wells points to the recent Works in Progress essay “Why we didn’t get a malaria vaccine sooner” by Saloni Dattani and MSA’s Rachel Glennerster and Siddhartha Haria. He discusses how Advance Market Commitments can help address weak profit incentives for developing and distributing vaccines.